Skip to content
Menu

Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $47

Benzinga Newsdesk 6 months ago

NewsPrice TargetAnalyst Ratings

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $38 to $47.

Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $38 to $47.

Read at benzinga.com